| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V73572 | 8-Bromo-ATP (8-Bromoadenosine 5'-triphosphate; 8-Br-ATP) | 23567-97-7 | 8-Bromo-ATP (8-Bromoadenosine 5'-triphosphate), an ATP analog, is an agonist of the purinergic P2X receptor. |
|
V2791 | A-317491 | 475205-49-3 | A-317491 is a selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, which inhibits calcium flux mediated by the receptors. |
|
V77029 | EVT-401 | 951015-69-3 | EVT-401 (P2X7 receptor blocker (antagonist)-1) is a purinergic P2X7 receptor blocker (antagonist). |
|
V80047 | H-Lys-Tyr-OH TFA (Lysyltyrosine TFA) | H-Lys-Tyr-OH TFA (Lysyltyrosine TFA) is a dipeptide consisting of L-lysine and L-tyrosine. | |
|
V115688 | HW091077 | 2766757-56-4 | HW091077 is a highly selective P2X3 receptor antagonist with an IC50 value of 17 nM. |
|
V80837 | MRS4596 | 2840581-38-4 | MRS4596 is a potent and specific P2X4 receptor antagonist (inhibitor) with IC50 of 1.38 μM for human P2X4 receptor. |
|
V140446 | MSK-9 | MSK-9 is a positive allosteric modulator of the P2X4 receptor, which has the dual effects of enhancing ion conductance and delaying receptor inactivation. | |
|
V99840 | P2X3 antagonist 39 | P2X3 antagonist 39 (Compound 26a) is a selective P2X3 receptor antagonist with IC50 of 54.9 nM. | |
|
V88981 | PPADS | 149017-66-3 | PPADS is a P2 receptor antagonist with IC50 of 68 nM (P2X1) and 214 nM (P2X3). |
|
V93696 | Relicpixant | 2445366-94-7 | Relicpixant is a potent purinergic receptor (P2X) antagonist. |
|
V87211 | Uridine adenosine tetraphosphate | 10527-48-7 | Uridine adenosine tetraphosphate (UP4A) is an endothelium-derived vasoconstrictor that primarily acts through the P2X1 receptor and may also act through the P2Y2 and P2Y4 receptors. |
|
V73577 | α,β-Methylene-ATP | 7292-42-4 | α,β-Methylene ATP is a phosphonate analog of ATP and a ligand for P2X3 and P2X7 receptors. |